In the latest trading session,, 1.93 million BioRestorative Therapies Inc (NASDAQ:BRTX) shares changed hands as the company’s beta touched 76.50. With the company’s most recent per share price at $1.78 changed hands at -$0.02 or -1.39% at last look, the market valuation stands at $13.36M. BRTX’s current price is a discount, trading about -43.26% off its 52-week high of $2.55. The share price had its 52-week low at $1.03, which suggests the last value was 42.13% up since then.

BioRestorative Therapies Inc (NASDAQ:BRTX) trade information

Instantly BRTX was in red as seen in intraday trades today. With action -1.11%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 24.48%, with the 5-day performance at -1.11% in the red. However, in the 30-day time frame, BioRestorative Therapies Inc (NASDAQ:BRTX) is -2.23% down.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 78.69%. The 2025 estimates are for BioRestorative Therapies Inc earnings to decrease by -44.40%.

BRTX Dividends

BioRestorative Therapies Inc is expected to release its next quarterly earnings report in July.

STONEX GROUP INC. holds the second largest percentage of outstanding shares, with 0.751% or 50100.0 shares worth $0.1 million as of 2024-06-30.

Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . With 29.73 shares estimated at $52770.0 under it, the former controlled 3.41% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held about 3.15% of the shares, roughly 27.46 shares worth around $48737.0.